Home       Market Dynamics     Sector Analysis     Company Insights     AI Investing     Strategies     Contact Us     Login             

JOHNSON & JOHNSON (JNJ) Stock Price Prediction and News Highlight
Fri. Mar 21, 2025

Johnson & Johnson is experiencing significant advancements in product and service development, particularly in oncology treatments like RYBREVANT and LAZCLUZE, which are showing promising patient outcomes. Their commitment to healthcare innovation and the development of treatments such as nipocalimab highlight their focus on addressing unmet medical needs. This emphasis on clinical trial results and transparency further underscores their dedication to accountability in presenting new medical solutions. However, the complexities of navigating regulatory approvals and competition within the pharmaceutical sector remain challenges.

The price action of JOHNSON & JOHNSON (JNJ) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.3 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for JNJ since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.5, and the negative at -0.2 on 2025-03-21. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (3.1) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

JNJ
DateAttentionPricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Hourly
Trend
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2025-03-210%(0%)    0    0%    0.4          3.1    -1   
2025-03-180%(0%)    0    0%    0.3          2.7    -1   
2025-03-170%(0%)    0    0%    0.2          2    -1   
2025-03-140%(0%)    0    0%    0.1          1.6    -1   
2025-03-130%(0%)    0    0%    0          1.2    -1   
2025-03-120%(0%)    0    0%    0.2          2    -1   
2025-03-060%(0%)    0    0%    0.1          1.8    -1   
2025-02-250%(0%)    0    0%    0.5          3.9    -1   
2025-02-230%(0%)    0    0%    0.4          3.1    -1   
2025-02-180%(0%)    0    0%    0.2          2.2    -1   
 
Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.
Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2025-06-11 22:24:14 The outperformance of Dividend Kings exemplifies their sustained competitive positioning within the industry amidst challenging economic environments.
2025-06-11 22:24:14 Johnson & Johnson's commitment to developing innovative healthcare products like Tremfya signifies a focus on addressing unmet medical needs.
2025-06-11 22:24:14 The performance of Dividend Kings against the S&P 500 emphasizes the uncertainty and volatility in market conditions for investors.
2025-06-11 22:24:14 The FDA's approval of J&J's Tremfya for Crohn's disease highlights regulatory support for new treatments, showcasing advancements in healthcare.
2025-06-11 22:24:14 Johnson & Johnson's significant investment of over $55 billion in the U.S. indicates a strong commitment to growth and development in the healthcare sector.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA